Sign in

    Joseph Vidich

    Research Analyst at Manalapan Oracle Capital Management

    Joseph Vidich is the Managing Member of Manalapan Oracle Capital Management, focusing on active equity investment strategies and company analysis. He has engaged with companies such as Northern Technologies International Corporation (NTIC), Trinity Biotech, and Hyster-Yale through earnings calls and investment forums, and is recognized for his emphasis on risk management and disciplined position sizing. Vidich has overseen Manalapan Oracle since at least 2012, though the firm's last public 13F equity filing was in Q3 2012, and maintains active participation in company research and portfolio oversight. Based in New Jersey, he is listed as an officer of Manalapan Oracle in SEC Form ADV filings, reflecting his registration and compliance as a professional investment adviser.

    Joseph Vidich's questions to NORTHERN TECHNOLOGIES INTERNATIONAL (NTIC) leadership

    Joseph Vidich's questions to NORTHERN TECHNOLOGIES INTERNATIONAL (NTIC) leadership • Q4 2024

    Question

    Inquired about the status and timeline of a U.S. certification for Zerust Oil & Gas technology, its potential impact on global adoption, and recent business developments in South America, particularly Brazil.

    Answer

    An API change regarding VCI use is expected in late fiscal 2025, which should boost credibility and adoption in the U.S. and subsequently globally, as many regions follow U.S. guidelines. In South America, there has been strong growth in Brazil's oil and gas sector, particularly with Petrobras and its suppliers, prompting the company to invest in expanding its infrastructure in the region to support further growth.

    Ask Fintool Equity Research AI